original ) (raw )The awareness, efficacy, safety, and time in therapeutic range of warfarin in the Turkish population: warfarin -tr
MEHMET ALİ KOBAT
The Anatolian Journal of Cardiology, 2015
View PDFchevron_right
A prospective study on the use of warfarin in the United arab emirates
asim elnour
The open cardiovascular medicine journal, 2012
View PDFchevron_right
Effect of patient-specific factors on weekly warfarin dose
Heather Whitley
Therapeutics and clinical risk management, 2007
View PDFchevron_right
Efficacy and Safety of Warfarin Therapy: Comparison Between Specialized INR Clinic and General Medical Clinic
Rayan Khalid
Sudan Journal of Medical Sciences
View PDFchevron_right
Evaluation of quality of warfarin therapy by assessing patient's time in therapeutic range at a tertiary care hospital in Pakistan
Ayesha Abbasi
2018
View PDFchevron_right
Comparison of the real-life clinical outcomes of warfarin with effective time in therapeutic range and non-vitamin K antagonist oral anticoagulants: Insight from the AFTER-2 trial
Muhammed Demir
Kardiologia Polska
View PDFchevron_right
Major Determinants of Outcome and Dosing in Warfarin Treatment
Jonatan Lindh
View PDFchevron_right
Comparison of Warfarin use in terms of efficacy and safety in two different polyclinics
Burcu YAĞMUR
Anatolian journal of cardiology, 2017
View PDFchevron_right
Potential factors affecting the anticoagulation control in patients treated with warfarin: Results WARFARIN-TR study
Salih Salman Kılıç
International Journal of the Cardiovascular Academy, 2018
View PDFchevron_right
Factors Associated with the Use of Warfarin and the Risk of Bleeding: Cross-Sectional Study
Abdulrahman Alammari
2019
View PDFchevron_right
Evaluation of an Initiation Regimen of Warfarin for International Normalized Ratio Target 2.0 to 3.0
ahlam naila
Journal of Pharmacy Technology, 2021
View PDFchevron_right
Validation of a Knowledge Test in Turkish Patients on Warfarin Therapy at an Ambulatory Anticoagulation Clinic
Meltem Türker
Turkish journal of pharmaceutical sciences, 2021
View PDFchevron_right
Investigation of Education Requirements of Individuals Using Warfarin and Achievement of Target INR Value
Hayat Yalın
Letters in Applied NanoBioScience, 2021
View PDFchevron_right
Assessment of Anticoagulation Control Association with Warfarin Knowledge and Demographic Features of Iranian Population
Iman Harirforoosh
Multidisciplinary Cardiovascular Annals
View PDFchevron_right
Evaluation of Warfarin Oral Used by International Normalized Ratio Value and Determination Frequency to Cardiovascular Patient at Haji Adam Malik General Hospital, Medan, Indonesia
parlindungan manik
Asian Journal of Pharmaceutical and Clinical Research
View PDFchevron_right
Potential Causes and Implications of Low Target Therapeutic Ratio in Warfarin-Treated Patients for Thrombosis Prophylaxis
Mehmet Agirbasli
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2017
View PDFchevron_right
Warfarin Therapy: Survey of Patients' Knowledge of their Drug Regimen
Hassan Shahid
The Malaysian journal of medical sciences : MJMS, 2014
View PDFchevron_right
The investigation of the relation between inr levels and risk of complication in patients with a history of warfarin use
Haldun Akoglu
2012
View PDFchevron_right
Özdemir S, Ünsal P. Warfarin Treatment: Home Health Services Versus Outpatient Clinics. Erciyes Med J 2021; 43(5): 438–42.
Journal of Clinical Practice and Research
Erciyes Medical Journal, 2021
View PDFchevron_right
Validation and comparison between two warfarin dosing clinical algorithms and warfarin fixed dosing in specialized heart center: cross-sectional study
Mohamed Elmustafa
Pharmacy Practice
View PDFchevron_right
Determining Risk Factors of Bleeding in Patients on Warfarin Treatment
semra erdoğan
Advances in Hematology, 2014
View PDFchevron_right
Evaluation of the impact of warfarin’s time-in-therapeutic range on outcomes of patients with atrial fibrillation in Turkey: Perspectives from the Observational, Prospective WATER Registry
Mehmet Emre Ozpelit
Cardiology Journal, 2013
View PDFchevron_right
Evaluation of the impact of warfarin time in therapeutic range on outcomes of patients with atrial fibrillation in Turkey: Perspectives from the observational, prospective WATER Registry
Uğur Önsel Türk
Cardiology Journal, 2015
View PDFchevron_right
The Factors Associated with Bleeding in Patients Using Warfarin
latif duran
Kırıkkale Üniversitesi Tıp Fakültesi Dergisi, 2021
View PDFchevron_right
Quality of warfarin management in primary care: Determining the stability of international normalized ratios using a nationally representative prospective cohort
Scott Garrison
Canadian family physician Medecin de famille canadien, 2019
View PDFchevron_right
Association of Inr Quality with Complications Among Patients on Warfarin Therapy in Hospital Sultan Ismail Petra, Kelantan State
Adnin Abdullah
International Journal of Public Health and Clinical Sciences, 2020
View PDFchevron_right
Predisposing Preventable Factors in Patients With Bleeding due to Warfarin Usage: Evaluation of 114 Patients
Cengiz Beyan
Clinical and Applied Thrombosis-hemostasis, 2010
View PDFchevron_right
Comparison of risk factors for warfarin-associated bleeding
Meriç Özgenel
Ankara Medical Journal
View PDFchevron_right